Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 3:3:261.
doi: 10.3389/fimmu.2012.00261. eCollection 2012.

Emerging Functions of RANKL in Lymphoid Tissues

Affiliations

Emerging Functions of RANKL in Lymphoid Tissues

Christopher G Mueller et al. Front Immunol. .

Abstract

The tumor necrosis factor superfamily (TNFSF) members play pivotal roles in embryonic development of lymphoid tissue and their homeostasis. RANKL (Receptor activator of NF-κB ligand, also called TRANCE, TNFSF11) is recognized as an important player in bone homeostasis and lymphoid tissue formation. In its absence bone mass control is deregulated and lymph nodes fail to develop. While its function in bone is well described, there is still little functional insight into the action of RANKL in lymphoid tissue development and homeostasis. Here we provide an overview of the known functions of RANKL, its signaling receptor RANK and its decoy receptor OPG from the perspective of lymphoid tissue development and immune activation in the mouse. Expressed by the hematopoietic lymphoid tissue inducing (LTi) cells and the mesenchymal lymphoid tissue organizer (LTo) cells, RANKL was shown to stimulate Lymphotoxin (LT) expression and to be implicated in LTi cell accumulation. Our recent finding that RANKL also triggers proliferation of adult lymph node stroma suggests that RANKL may furthermore directly activate LTo cells. Beyond bone, the RANKL-RANK-OPG triad plays important roles in immunobiology that are waiting to be unraveled.

Keywords: LTi; LTo; OPG; TNFSF11; TRANCE; lymph node; lymphoid organs; stroma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
RANKL function in the bone, the adaptive immune system and the vascular system. (A) RANKL produced by bone marrow stroma (osteoblasts and osteocytes) directs the differentiation of preosteoclasts of the myeloid lineage into mature osteoclasts. Stroma-derived OPG negatively regulates RANKL-RANK interaction. (B) Activated T cells express RANKL that stimulates dendritic cell survival and maturation. (C) Endothelium is a source for RANKL and OPG. RANK-activation of endothelial cells supports cell survival and promotes angiogenesis.
Figure 2
Figure 2
RANKL-dependent amplification loops in SLO development. SLO development during embryogenesis is initiated by the recruitment of lymphoid tissue inducer (LTi) cells to a rudimentary organ anlage composed of mesenchymal lymphoid tissue organizer (LTo) cell progenitors. This step is followed by a cross-talk between LTi cells that express RANKL, RANK, and LTαβ and LTo cells that carry LTβR formula image. Engagement of the latter induces the maturation of LTo cells formula image to express RANKL and chemokines that attract larger numbers of LTi cells that upon clustering with LTo cells initiate LN organization. LTo cells also express RANKL. The current model of LN development indicates that a positive feedback loop takes place between LTo and LTi cells via RANKL-RANK and LTαβ-LTβR amplifying the early stages of LN development formula image. If LTo cells expressed also RANK, a second (autocrine) loop may occur, leading to a direct activation of LTo cells formula image.

Similar articles

Cited by

References

    1. Akiyama T., Shimo Y., Yanai H., Qin J., Ohshima D., Maruyama Y., Asaumi Y., Kitazawa J., Takayanagi H., Penninger J. M., Matsumoto M., Nitta T., Takahama Y., Inoue J. (2008). The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29, 423–43710.1016/j.immuni.2008.06.015 - DOI - PubMed
    1. Alimzhanov M. B., Kuprash D. V., Kosco-Vilbois M. H., Luz A., Turetskaya R. L., Tarakhovsky A., Rajewsky K., Nedospasov S. A., Pfeffer K. (1997). Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94, 9302–930710.1073/pnas.94.17.9302 - DOI - PMC - PubMed
    1. Anderson D. M., Maraskovsky E., Billingsley W. L., Dougall W. C., Tometsko M. E., Roux E. R., Teepe M. C., DuBose R. F., Cosman D., Galibert L. (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175–17910.1038/36593 - DOI - PubMed
    1. Ansel K. M., Harris R. B., Cyster J. G. (2002). CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16, 67–7610.1016/S1074-7613(01)00257-6 - DOI - PubMed
    1. Ansel K. M., Ngo V. N., Hyman P. L., Luther S. A., Forster R., Sedgwick J. D., Browning J. L., Lipp M., Cyster J. G. (2000). A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309–31410.1038/35018581 - DOI - PubMed

LinkOut - more resources